Opportunity Information: Apply for PA 11 075
Apply for PA 11 075
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Ruth L. Kirschstein National Research Service Awards for Individual Postdoctoral Fellowships in Muscular Dystrophy Research (F32)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.846 Arthritis, Musculoskeletal and Skin Diseases Research.
- This funding opportunity was created on Dec 10, 2010 and posted on Dec 10, 2010.
- Applicants must submit their applications by Jan 7, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Non domestic (non U.S.) Entities (Foreign Organizations) Tribally Controlled Colleges and Universities (TCCUs) .
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship in Muscular Dystrophy Research (F32) is a National Institutes of Health (NIH) training-focused grant opportunity designed to support promising postdoctoral researchers who are building toward independent scientific careers. Administered through the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), this program specifically emphasizes postdoctoral training opportunities that strengthen the muscular dystrophy research workforce. The overall intent is not only to fund a research project, but to fund a mentored training experience that helps an applicant develop the skills, productivity, and scientific independence expected of a future investigator in health-related research areas aligned with NIAMS priorities.
The scientific scope centers on muscular dystrophies, and NIAMS indicates interest across the full research spectrum, including basic, translational, and clinical studies. Relevant disease areas explicitly include (but are not limited to) Duchenne muscular dystrophy, myotonic dystrophy, facioscapulohumeral muscular dystrophy, and congenital muscular dystrophies. In practical terms, this means proposed fellowship training plans can range from fundamental studies of disease mechanisms, to development and validation of therapeutic strategies, to patient-oriented or clinical research aimed at improving diagnosis, management, or outcomes, as long as the work clearly fits within muscular dystrophy research and is framed as a postdoctoral training experience.
This opportunity uses the Ruth L. Kirschstein NRSA F32 mechanism, which is a well-known NIH fellowship pathway for individual postdoctoral applicants. Under this mechanism, the fellow is the primary applicant, and the application is typically built around a structured mentorship plan, a defined training environment, and a research and career development plan that together demonstrate how the fellowship will accelerate the applicant toward independence. NIAMS uses this FOA to support additional postdoctoral training slots focused on muscular dystrophy topics, reinforcing that the emphasis is on cultivating researchers who will continue contributing to the field long-term.
Award size and duration are not fixed in a single uniform amount under this announcement. Instead, NIAMS notes that both the budget level and the length of support can vary depending on the nature and scope of the proposed training and research. The total funds awarded and the number of awards made are contingent on several factors, including the number of applications received, the scientific and training quality of those applications, the proposed duration, and the associated costs. There is no cost-sharing or matching requirement, meaning applicants and institutions are not required to provide matching funds as a condition of receiving an award.
Eligibility is broad at the institutional level and spans many organization types that may serve as the sponsoring institution for the fellowship. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofits with and without 501(c)(3) status (with the noted exception category), and for-profit organizations other than small businesses. The eligibility section also lists additional categories such as Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, and non-U.S. (foreign) organizations. This breadth signals NIAMS openness to a wide range of research training environments, including certain international settings, provided the application meets NIH and NRSA requirements for the fellowship mechanism.
Key administrative details in the source listing include the Funding Opportunity Number PA 11-075, classification as a discretionary grant in the health funding activity category, and the associated CFDA number 93.846 (Arthritis, Musculoskeletal and Skin Diseases Research). The opportunity was posted on December 10, 2010, with an original and current closing date of January 7, 2014, and an archive date of February 7, 2014, indicating it is no longer open under those dates. The full announcement was hosted through the NIH Grants Guide (link provided in the source), and general technical assistance for accessing the notice was directed to the NIH Office of Extramural Research (OER) webmaster contact.
Frequently Asked Questions (FAQs)
1) What is the NRSA Individual Postdoctoral Fellowship in Muscular Dystrophy Research (F32)?
This opportunity is the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship in Muscular Dystrophy Research (F32). It is an NIH training-focused fellowship designed to support promising postdoctoral researchers through a mentored training experience in muscular dystrophy research, with the goal of helping fellows progress toward independent scientific careers.
2) Which NIH institute administers this fellowship?
The fellowship is administered through the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health (NIH).
3) What is the main purpose of this funding opportunity: research project funding or training support?
The central intent is to fund a mentored postdoctoral training experience rather than only a standalone research project. The application is expected to show how the proposed research, mentorship, and training plan will build the fellow's skills, productivity, and scientific independence.
4) Who is the primary applicant under the F32 mechanism?
Under the NRSA F32 mechanism, the fellow is the primary applicant. The application is typically built around mentorship, the training environment, and the fellow's research and career development plans.
5) What scientific areas are within scope for this fellowship?
The scientific scope centers on muscular dystrophies. NIAMS indicates interest across the full research spectrum, including basic, translational, and clinical studies, as long as the work clearly fits within muscular dystrophy research and is framed as postdoctoral training.
6) Which muscular dystrophy diseases are specifically mentioned?
The announcement explicitly mentions Duchenne muscular dystrophy, myotonic dystrophy, facioscapulohumeral muscular dystrophy, and congenital muscular dystrophies, while also indicating that relevant disease areas are not limited to these examples.
7) Are clinical or patient-oriented studies allowed, or is the program limited to basic science?
Clinical and patient-oriented studies are included within the stated scope. NIAMS describes interest spanning basic, translational, and clinical research, including work aimed at improving diagnosis, management, or outcomes, provided it aligns with muscular dystrophy research and the postdoctoral training focus.
8) What does NIAMS emphasize about the training component?
NIAMS emphasizes that the fellowship should strengthen the muscular dystrophy research workforce by supporting mentored postdoctoral training that builds the applicant toward independence. The application is typically expected to include a structured mentorship plan, a defined training environment, and a research and career development plan.
9) Is the award amount fixed?
No. NIAMS notes that the budget level can vary depending on the nature and scope of the proposed training and research, and the overall funds awarded depend on factors such as application volume, application quality, duration, and associated costs.
10) Is the duration of support fixed?
No. NIAMS states that the length of support can vary depending on the proposed training and research plan.
11) Does the program require cost sharing or matching funds?
No. The listing states there is no cost-sharing or matching requirement, meaning applicants and institutions are not required to provide matching funds as a condition of receiving an award.
12) What types of institutions can serve as the sponsoring institution?
Eligibility is broad and includes public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (with and without 501(c)(3) status, with a noted exception category), and for-profit organizations other than small businesses.
13) Are minority-serving institutions included as eligible sponsoring institutions?
Yes. The eligibility list includes categories such as Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs).
14) Can federal agencies serve as eligible organizations?
Yes. The eligibility section includes eligible federal agencies.
15) Are non-U.S. (foreign) organizations eligible?
Yes. The eligibility list includes non-U.S. (foreign) organizations, indicating openness to certain international settings, as long as the application meets NIH and NRSA requirements for the fellowship mechanism.
16) What is the Funding Opportunity Number for this announcement?
The Funding Opportunity Number listed is PA 11-075.
17) What is the CFDA number associated with this opportunity?
The associated CFDA number is 93.846, labeled as Arthritis, Musculoskeletal and Skin Diseases Research.
18) What is the funding activity category and grant classification?
The listing classifies this as a discretionary grant in the health funding activity category.
19) When was this opportunity posted, and what were the listed closing dates?
The opportunity was posted on December 10, 2010. The original and current closing date listed is January 7, 2014, and the archive date is February 7, 2014.
20) Is this funding opportunity currently open?
Based on the posted closing date of January 7, 2014 and the archive date of February 7, 2014, the listing indicates the opportunity is no longer open under those dates.
21) Where was the full announcement hosted?
The full announcement was hosted through the NIH Grants Guide (a link was provided in the source listing).
22) Who was listed for technical assistance regarding access to the notice?
The source listing directed general technical assistance for accessing the notice to the NIH Office of Extramural Research (OER) webmaster contact.
Browse more opportunities from the same category: Health
Next opportunity: Engage Youth with Starry Skies
Previous opportunity: The Association of Genetic Biomarkers and Hereditary Hemochromatosis (U01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 11 075
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 11 075) also looked into and applied for these:
| Funding Opportunity |
|---|
| Informatics Tools for High Throughput Sequence Data Analysis (SBIR) (R43/R44) Apply for RFA HG 10 019 Funding Number: RFA HG 10 019 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Informatics Tools for High Throughput Sequence Data Analysis (U01) Apply for RFA HG 10 018 Funding Number: RFA HG 10 018 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Research Activities In Support Of Malaria Prevention and Control in the Republic Of Uganda As Part of the President s Malaria Initiative Apply for RFA GH 11 004 Funding Number: RFA GH 11 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Pilot for State specific Cross Sectional Surveillance of Persons with Rare Disorders and Longitudinal Assessment of Outcomes Apply for RFA DD 11 004 Funding Number: RFA DD 11 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Mendelian Disorders Genome Centers (U54) Apply for RFA HG 10 016 Funding Number: RFA HG 10 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Genome Sequencing and Analysis Centers (U54) Apply for RFA HG 10 015 Funding Number: RFA HG 10 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Muscular Dystrophy Surveillance Tracking and Research Network MD STARnet Feasibility of Expansion to other Muscular Dystrophies Apply for RFA DD 11 006 Funding Number: RFA DD 11 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $450,000 |
| Limited Competition for the Renewal of the National Cell Repository for Alzheimers Disease (NCRAD) (U24) Apply for PAR 11 080 Funding Number: PAR 11 080 Agency: National Institutes of Health Category: Health Funding Amount: $675,000 |
| Expanding Maternal and Neonatal Survival (EMAS) Apply for RFA 497 11 000002 Funding Number: RFA 497 11 000002 Agency: Indonesia USAID Jakarta Category: Health Funding Amount: $55,000,000 |
| HIV Prevention with Youth and Adults Program in Lesotho Apply for 674 11 0004 Funding Number: 674 11 0004 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $17,000,000 |
| Clinical Sequencing Exploratory Research (U01) Apply for RFA HG 10 017 Funding Number: RFA HG 10 017 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Development of a Preliminary Evidence Base to Inform Decision making about Returning Research Results to Participants in Genomic Studies (R01) Apply for RFA HG 11 003 Funding Number: RFA HG 11 003 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Ethical, Legal, and Social Implications of Returning Research Results to Genomic Research Participants (R21) Apply for RFA HG 11 004 Funding Number: RFA HG 11 004 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Long Term MCH Training LEND Apply for HRSA 11 036 Funding Number: HRSA 11 036 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Disparities in Perinatal Health Border, Alaska and Hawaii Apply for HRSA 11 018 Funding Number: HRSA 11 018 Agency: Health Resources and Services Administration Category: Health Funding Amount: $750,000 |
| Improving Access to Hearing Health Care (STTR) R41/R42 Apply for RFA DC 12 002 Funding Number: RFA DC 12 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Access to Hearing Health Care (SBIR) R43/R44 Apply for RFA DC 12 001 Funding Number: RFA DC 12 001 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Ability of Individual and Integrated Tick Management (ITM) Technologies to Reduce the Entomological Risk of Lyme Disease Apply for RFA CK 11 005 Funding Number: RFA CK 11 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Combining Subjective and Objective Methods for Quantifying Contact Rates and Mixing Pattern in School Aged Children Apply for RFA CK 11 006 Funding Number: RFA CK 11 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Pathophysiology and Clinical Studies of Osteonecrosis of the Jaw (R21) Apply for PAR 11 083 Funding Number: PAR 11 083 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 11 075", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.